Skip to content
Parker Institute for Cancer Immunotherapy
Search Close

From Pediatric Cancer Challenges to CAR T Cell Signaling with Robbie Majzner, MD

In this episode, Robbie Majzner, MD, a PICI Investigator at the Dana-Farber Cancer Institute, sits down with PICI Chief Scientific Officer John Connolly, PhD, to discuss efforts to engineer next-generation CAR T cells using synthetic biology to enhance the therapeutic potential for fatal pediatric cancers. Formerly a researcher at Stanford University, where he was mentored by Crystal Mackall, MD, Center Director for the PICI Center at Stanford Medicine, Robbie is among the founding members of Cargo Therapeutics, a PICI investment company.

Listen as Robbie covers collaboration in the pediatric oncology field, the distinct characteristics of pediatric cancers and their immuno-biology versus adult cancers, and drug development obstacles for children.

Get ready to go from bench to fireside with Robbie Majzner, MD.

Listen on Spotify